ITGAL antibody
Quick Overview for ITGAL antibody (ABIN7865659)
Target
See all ITGAL AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- anti-CD11a mouse monoclonal, 87-6F9, purified
-
Purification
- affinity chromatography
-
Immunogen
- stimulated human leucocytes
-
Isotype
- IgG2b kappa
-
-
-
-
Application Notes
-
ICC/IF_dilution: assay dependent
FACS_dilution: 0.5-1.0 μg/million cells in 0.1 ml
WB_dilution: 1:50-1:100 (1-2 μg/mL)
IHC-frozen_dilution: 1:50-1:100 (1-2 μg/mL)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 100 μg/mL
-
Buffer
- PBS with 0.02 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- store at 2 - 8 °C
-
-
- ITGAL (Integrin alpha-L (ITGAL))
-
Alternative Name
- CD11a
-
Background
- 87-6F9 Reacts with CD11a, a transmembrane molecule with 1145 amino acid residues and a MW of 180 kDa. CD11a is expressed on lymphocytes, granulocytes, monocytes and macrophages. Levels on memory T-cells tend to increase. CD11a plays a key role in mediating leukocyte adhesion to endothelium during inflammatory response through binding to ICAM 1 (CD54). Other ligands are ICAM-2 and ICAM-3. It is also involved in many other T-cell functions and immune phenomena. When paired with CD18, it forms the integrin alphaLbeta2 adhesion. 87-6F9 potently blocks LFA-1 dependent homotypic cell aggregation and was typed in the IVth International Leucocyte Typing Workshop. Positive control: Human leucocytes.
-
Pathways
- Activated T Cell Proliferation, Integrin Complex
Target
-